European Journal of Radiology
Volume 40, Issue 3 , Pages 198-207 , December 2001

Molecular and radiological diagnosis of sclerosing bone dysplasias

  • Wim Van Hul

      Affiliations

    • Department of Medical Genetics, University of Antwerp, Universiteitsplein 1, 2610 Wilrijk, Antwerp, Belgium
    • Corresponding Author InformationCorresponding author. Tel.: +32-3-820-2585; fax: +32-3-820-2566
    • ,
  • Filip Vanhoenacker

      Affiliations

    • Department of Radiology, University Hospital Antwerp, Wilrijkstraat 10, B-2650 , Edegem, Belgium
    • Tel.: +32-3-821-3532; fax: +32-3-825-2026.
    • ,
  • Wendy Balemans

      Affiliations

    • Department of Medical Genetics, University of Antwerp, Universiteitsplein 1, 2610 Wilrijk, Antwerp, Belgium
    • ,
  • Katrien Janssens

      Affiliations

    • Department of Medical Genetics, University of Antwerp, Universiteitsplein 1, 2610 Wilrijk, Antwerp, Belgium
    • ,
  • A.M De Schepper

      Affiliations

    • Department of Radiology, University Hospital Antwerp, Wilrijkstraat 10, B-2650 , Edegem, Belgium

Received 16 July 2001 ,Revised 17 July 2001 ,Accepted 18 July 2001.

References 

  1. International Working Group on Constitutional Disease of Bone . International Nomenclature and Classification of the Osteochondrodysplasias 1997. Am. J. Med. Genet. 1998;79:376–382
  2. Sly WS, Hewett-Emmett D, Whyte MP, Yu YS, Tashian RE. Carbonic anhydrase II deficiency identified as the primary defect in the autosomal recessive syndrome of osteopetrosis with renal tubular acidosis and cerebral calcification. Proc. Natl. Acad. Sci. USA. 1983;80:2752–2756
  3. Polymeropoulos MH, Ortiz De Luna RI, Ide SE, Torres R, Rubenstein J, Francomano CA. The gene for pycnodysostosis maps to human chromosome 1cen-q21. Nat. Genet. 1995;10:238–239
  4. Gerritsen EJ, Vossen JM, van Loo IH, Hermans J, Helfrich MH, Griscelli C, et al. Autosomal recessive osteopetrosis: variability of findings at diagnosis and during the natural course. Pediatrics. 1994;932:247–253
  5. Gerritsen EJ, Vossen JM, Fasth A, Friedrich W, Morgan G, Padmos A, et al. Bone marrow transplantation for autosomal recessive osteopetrosis. A report from the Working Party on Inborn Errors of the European Bone Marrow Transplantation Group. J. Pediatr. 1994;1256:896–902
  6. Key LL, Rodriguiz RM, Willi SM, Wright NM, Hatcher HC, Eyre DR, et al. Long-term treatment of osteopetrosis with recombinant human interferon gamma. N. Engl. J. Med. 1995;332:1594–1599
  7. Frattini A, Orchard PJ, Sobacchi C, Giliani S, Abinun M, Mattsson JP, et al. Defects in TCIRG1 subunit of the vacuolar proton pump are responsible for a subset of human autosomal recessive osteopetrosis. Nat. Genet. 2000;25:343–346
  8. Kornak U, Schulz A, Friedrich W, Uhlhaas S, Kremens B, Voit T, et al. Mutations in the a3 subunit of the vacuolar H+-ATPase cause infantile malignant osteopetrosis. Hum. Mol. Genet. 2000;9:2059–2063
  9. Kornak U, Kasper D, Bosl MR, Kaiser E, Schweizer M, Schulz A, et al. Loss of the ClC-7 chloride channel leads to osteopetrosis in mice and man. Cell. 2001;104:205–215
  10. Roth DE, Venta PJ, Tashian RE, Sly WS. Molecular basis of human carbonic anhydrase II deficiency. Proc. Natl. Acad. Sci. USA. 1992;89:1804–1808
  11. Kahler SG, Burns JA, Aylsworth AS. A mild autosomal recessive form of osteopetrosis. Am. J. Med. Genet. 1984;172:451–464
  12. Bollerslev J. Autosomal dominant osteopetrosis: bone metabolism and epidemiological, clinical, and hormonal aspects. Endocr. Rev. 1989;101:45–67
  13. Bollerslev J, Andersen PE. Radiological, biochemical and hereditary evidence of two types of autosomal dominant osteopetrosis. Bone. 1988;91:7–13
  14. Vanhoenacker FM, De Beuckeleer LH, Van Hul W, Balemans W, Tan GJ, Hill SC, et al. Sclerosing bone dysplasias: genetic and radioclinical features. Eur. Radiol. 2000;10:1423–1433
  15. Van Hul E, Mathysen D, Bollerslev J, Gram J, Van Hul W. Autosomal dominant osteopetrosis type I is genetically linked to the same region on human chromosome 11 as the high bone mass phenotype. J. Bone Miner Res. 2000;15:S260
  16. Van Hul W, Bollerslev J, Gram J, Van Hul E, Wuyts W, Benichou O, et al. Localization of a gene for autosomal dominant osteopetrosis Albers-Schonberg disease to chromosome 1p21. Am. J. Hum. Genet. 1997;61:363–369
  17. White KE, Koller DL, Takacs I, Buckwalter KA, Foroud T, Econs MJ. Locus heterogeneity of autosomal dominant osteopetrosis ADO. J. Clin. Endoc. Metab. 1999;84:1047–1051
  18. Benichou OD, Benichou B, Copin H, De Vernejoul MC, Van Hul W. Further evidence for genetic heterogeneity within type II autosomal dominant osteopetrosis. J. Bone Miner Res. 2000;15:1900–1904
  19. Maroteaux P, Lamy M. La pycnodysostose. Presse Med. 1962;70:999–1002
  20. Gelb BD, Shi GP, Chapman HA, Desnick RJ. Pycnodysostosis, a lysosomal disease caused by cathepsin K deficiency. Science. 1996;273:1236–1238
  21. Horan FT, Beighton PH. Osteopathia striata with cranial sclerosis: an autosomal dominant entity. Clin. Genet. 1978;13:201–206
  22. Bueno AL, Ramos FF, Bueno O, Olivares JL, Bello ML, Bueno M. Severe malformations in males from families with osteopathia striata with cranial sclerosis. Clin. Genet. 1998;54:400–405
  23. Behninger C, Rott HD. Osteopathia striata with cranial sclerosis: literature reappraisal argues for X-linked inheritance. Genet. Couns. 2000;11:157–167
  24. Freyschmidt J. Melorheostosis: a review of 23 cases. Eur. Radiol. 2001;11:474–479
  25. Greenspan A. Sclerosing bone dysplasias: a target-site approach. Skeletal Radiol. 1991;20:561–583
  26. Naveh Y, Kaftori JK, Alon U, Ben-David J, Berant M. Progressive diaphyseal dysplasia: genetics and clinical and radiologic manifestations. Pediatrics. 1984;743:399–405
  27. Kaftori JK, Kleinhaus U, Naveh Y. Progressive diaphyseal dysplasia (Camurati–Engelmann): radiographic follow-up and CT findings. Radiology. 1987;164:777–782
  28. Janssens K, Gershoni-Baruch R, Van Hul E, Brik R, Guanabens N, Migone N, et al. Localisation of the gene causing diaphyseal dysplasia Camurati–Engelmann to chromosome 19q13. J. Med. Genet. 2000;37:245–249
  29. Ghadami M, Makita Y, Yoshida K, Nishimura G, Fukushima Y, Wakui K, et al. Genetic mapping of the Camurati–Engelmann disease locus to chromosome19q13.1–q13.3. Am. J. Hum. Genet. 2000;66:143–147
  30. Kinoshita A, Saito T, Tomita Ha, Makita Y, Yoshida K, Ghadami M, et al. Domain-specific mutations in TGFB1 result in Camurati–Engelmann disease. Nat. Genet. 2000;26:19–20
  31. Janssens K, Gershoni-Baruch R, Guanabens N, Migone N, Ralston S, Bonduelle M, et al. Mutations in the gene encoding the latency-associated peptide of TGF-beta1 cause Camurati–Engelmann disease. Nat. Genet. 2000;26:273–275
  32. van Buchem FS. Hyperostosis corticalis generalisata. Eight new cases. Acta Med. Scand. 1971;1894:257–267
  33. Van Hul W, Balemans W, Van Hul E, Dikkers FG, Obee H, Stokroos RJ, et al. Van Buchem disease hyperostosis corticalis generalisata maps to chromosome 17q12–q21. Am. J. Hum. Genet. 1998;62:391–399
  34. Worth HM, Wollin DG. Hyperostosis corticalis generalisata congenita. J. Can. Assoc. Radiol. 1966;172:67–74
  35. Beighton P, Barnard A, Hamersma H, van der Wouden A. The syndromic status of sclerosteosis and van Buchem disease. Clin. Genet. 1984;25:175–181
  36. Beighton P. Sclerosteosis. J. Med. Genet. 1988;253:200–203
  37. Balemans W, Van Den Ende J, Freire Paes-Alves A, Dikkers FG, Willems PJ, Vanhoenacker F, et al. Localization of the gene for sclerosteosis to the van Buchem disease-gene region on chromosome 17q12–q21. Am. J. Hum. Genet. 1999;64:1661–1669
  38. Balemans W, Ebeling M, Patel N, Van Hul E, Olson P, Dioszegi M, et al. Increased bone density in sclerosteosis is due to the deficiency of a novel secreted protein SOST. Hum. Mol. Genet. 2001;10:537–543
  39. Brunkow ME, Gardner JC, Van Ness J, Paeper BW, Kovacevich BR, Proll S, et al. Bone dysplasia sclerosteosis results from loss of the SOST gene product, a novel cystine knot-containing protein. Am. J. Hum. Genet. 2001;68:577–589
  40. Lachman RS. Skeletal dysplasias. In:  Taybi H,  Lachman RS editor. Radiology of Syndromes, Metabolic Disorders, and Skeletal Dysplasias. St. Louis: Mosby-Year Book; 1996;
  41. Khan KTS, Uma R, Usha R, Al Ghanem MM, Al Awadi SA, Farag TI. Kenny–Caffey syndrome in six Bedouin sibships: autosomal recessive inheritance is confirmed. Am. J. Med. Genet. 1997;69:126–132
  42. Diaz GA, Khan KT, Gelb BD. The autosomal recessive Kenny-Caffey syndrome locus maps to chromosome 1q42–q43. Genomics. 1998;54:13–18
  43. Beighton P. Pyle disease (metaphyseal dysplasia). J. Med. Genet. 1987;24:321–324
  44. Gorlin RJ, Spranger J, Koszalka MF. Genetic craniotubular bone dysplasias and hyperostoses: a critical analysis. Birth Defects Orig. Art. Ser. V. 1969;4:79–95
  45. Nurnberg P, Tinschert S, Mrug M, Hampe J, Muller CR, Fuhrmann E, et al. The gene for autosomal dominant craniometaphyseal dysplasia maps to chromosome 5p and is distinct from the growth hormone-receptor gene. Am. J. Hum. Genet. 1997;61:918–923
  46. Nurnberg P, Thiele H, Chandler D, Hohne W, Cunningham ML, Ritter H, et al. Heterozygous mutations in ANKH, the human ortholog of the mouse progressive ankylosis gene, result in craniometaphyseal dysplasia. Nat. Genet. 2001;28:37–41
  47. Hart TC, Bowden DW, Bolyard J, Kula K, Hall K, Wright JT. Genetic linkage of the tricho-dento-osseous syndrome to chromosome 17q21. Hum. Mol. Genet. 1997;6:2279–2284
  48. Price JA, Bowden DW, Wright JT, Pettenati MJ, Hart TC. Identification of a mutation in DLX3 associated with tricho-dento-osseous TDO syndrome. Hum. Mol. Genet. 1998;7:563–569
  49. Karaplis AC, He B, Nguyen MT, Young ID, Semeraro D, Ozawa H, et al. Inactivating mutation in the human parathyroid hormone receptor type 1 gene in Blomstrand chondrodysplasia. Endocrinology. 1998;13 912:5255–5258
  50. Zhang P, Jobert AS, Couvineau A, Silve C. A homozygous inactivating mutation in the parathyroid hormone/parathyroid hormone-related peptide receptor causing Blomstrand chondrodysplasia. J. Clin. Endocrinol. Metab. 1998;839:3365–3368
  51. Karperien M, van der Harten HJ, van Schooten R, Farih-Sips H, den Hollander NS, Kneppers SL, et al. A frame-shift mutation in the type I parathyroid hormone PTH/PTH-related peptide receptor causing Blomstrand lethal osteochondrodysplasia. J. Clin. Endocrinol. Metab. 1999;84:3713–3720

PII: S0720-048X(01)00400-4

European Journal of Radiology
Volume 40, Issue 3 , Pages 198-207 , December 2001

Article Tools

* Image Usage & Resolution